Abstract:W e have read with a great interest the article by Mulé et al. [1] on the association between glomerular filtration rate (GFR) and aortic root dilatation (ARD) in 611 hypertensive patients. The authors found an inverse relation between GFR and ARD indexed to body surface area (ARD/BSA) and height (ARD/height) after adjustment of multiple confounders, which highlighted the link between CKD and enhanced cardiovascular risk mediated by the effect of ARD. Given the important implication of this issue and the different effects of race, we tested this relationship in our general population consisting of 5538 Chinese hypertensive patients. From January 2012 to August 2013, a representative sample aged at least 35 years was selected to describe the prevalence, incidence, and natural history of cardiovascular risk factors in rural areas of Liaoning Province in northeast China, using a multistage, stratified random cluster-sampling scheme. The detailed process has been described elsewhere [2]. Aortic annular diameter was measured from trailing edge to leading edge at the hinging points of the aortic cusps to the annulus in the long-axis view that maximized this dimension by two-dimensional echocardiography [3]. GFR was estimated using the CKD Epidemiology Collaboration equation [4]. Considering the crucial effects of age on aortic size, we performed the analyses stratified by age ( 35 and<45; 45 and <55; 55 and <65; 65 years). After confirmation of linearity as well as statistical independence, homoscedasticity, and normality of the error distribution, we performed multiple linear regression analyses using an entry procedure to assess the independent correlates of GFR and ARD/BSA or ARD/height. Collinearity was considered as insignificant if the variance inflation factor is less than 5 [5]. As a result, we did not find any significant relation between estimated GFR and ARD/BSA or ARD/height after adjusting demographic characteristics, lifestyle factors, and clinical correlates (Table 1). Recent guidelines for hypertension management have recognized the relevance of aortic stiffness and renal dysfunction on cardiovascular prognosis [6], making it plausible to assume that CKD could deteriorate cardiovascular outcomes by dilating the aortic diameter. However, we failed to find supportive evidence for this assumption. The possible explanations of the discrepancy between the study by Mulé et al. and ours might on one hand be because of the different methods used for aortic size measurement, as also discussed by Mulé et al. [1]. On the other hand, we additionally adjusted confounders, including physical activity, left ventricular ejection fraction, and low-density lipoprotein that are all related to aortic function or atherosclerosis. Moreover, our participants were randomly selected from general population with a much lower prevalence of CKD and the different races per se might lead to the difference. We believe this interesting issue is worthy of more investigation and discussion.

Relationship between aortic root size and glomerular filtration rate in hypertensive patients.

Beneficial Properties and Mechanisms of Natural Phytochemicals to Combat and Prevent Hyperuricemia and Gout

On the stability of the solution in an optimal control problem for a Schrödinger equation

The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies

Hyperuricemia and its related diseases: mechanisms and advances in therapy

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions

Prevalence and Risk Factors of Hyperuricaemia in Non-Obese Chinese: a Single-Centre Cross-Sectional Study

Hyperuricemia and Nonalcoholic Fatty Liver Disease: from Bedside to Bench and Back

Effect of integrated Traditional Chinese and Western Medicine on Gout

Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components

The potential of Chinese medicines in the treatment of hyperuricemia

[Protective effects of bactericidal/permeability increasing protein simulated peptide on murine acute lung injury induced by lipopolysaccharide].

Advances in Experimental and Clinical Research of the Gouty Arthritis Treatment with Traditional Chinese Medicine

Diet Regulation and TCM Syndrome Differentiation and Treatment of Asymptomatic Hyperuricacidemia

The Therapeutic Management of Chemical and Herbal Medications on Uric Acid Levels and Gout: Modern and Traditional Wisdom

Progress in Treatment of Gout Using Chinese and Western Medicine

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease

Natural Bioactive Compounds: Emerging Therapies for Hyperuricemia

Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

Research progress of treating hyperuricemia in rats and mice with traditional Chinese medicine

The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications